ArticleiScience2025
Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors.
Giorgia Anastasio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleiScience2025
Giorgia Anastasio et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.